pooled analysis · 2010 · landmark
“Furthermore, there were no material associations with vascular risk at fasting blood glucose concentrations between 3·9 mmol/L and 5·6 mmol/L.”
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet
Who: individual records from 102 prospective studies of adults without initial vascular disease (mean age 52, 43% women, 96% Europe/North America/Australasia)
PMID 20609967
pooled analysis · 2010
“In analyses across tenths of fasting glucose values, adjusted HRs for CHD were generally weak and nonsignificant at levels below 7 mmol/l ( Figure 1 ).”
Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med
Who: Reykjavik cohort (Icelandic adults without history of MI) plus 26 Western prospective cohorts of people without diabetes
PMID 20520805
controlled trial · 2010
“Elevations in FPG in the non-diabetic range were not associated with long-term risk of cardiovascular events in middle-aged men in WOSCOPS.”
Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J
Who: 6447 moderately hypercholesterolaemic Scottish men (mean age 55) with no history of CVD or diabetes and fasting glucose <7.0 mmol/L (WOSCOPS)
PMID 20395260
trial or observed group · 2010 · landmark
“As compared with a baseline fasting glucose level of less than 100 mg per deciliter, a level of 100 to less than 126 mg per deciliter was associated with diagnosed diabetes (hazard ratio, 2.31; 95% CI, 2.06 to 2.59) but not with coronary heart disease (hazard ratio, 1.03; 95% CI, 0.91 to 1.18), ischemic stroke (hazard ratio, 0.97; 95% CI, 0.76 to 1.23), and death from any cause (hazard ratio, 1.07; 95% CI, 0.96 to 1.21) after adjustment for covariates (model 2b) (Table 3), whereas undiagnosed diabetes (defined as a fasting glucose level of 126 mg per deciliter or higher at baseline) was significantly, independently associated with the development of coronary heart disease (hazard ratio, 1.29; 95% CI, 1.04 to 1.61), ischemic stroke (hazard ratio, 1.89; 95% CI, 1.33 to 2.69), and death from any cause (hazard ratio, 1.31; 95% CI, 1.07 to 1.61).”
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med
Who: 11,092 black or white middle-aged adults in the ARIC study without a history of diabetes or cardiovascular disease
PMID 20200384